TY - JOUR
T1 - Analyzing longitudinal wb‐mri data and clinical course in a cohort of former smoldering multiple myeloma patients
T2 - Connections between mri findings and clinical progression patterns
AU - Wennmann, Markus
AU - Hielscher, Thomas
AU - Kintzelé, Laurent
AU - Menze, Bjoern H.
AU - Langs, Georg
AU - Merz, Maximilian
AU - Sauer, Sandra
AU - Kauczor, Hans Ulrich
AU - Schlemmer, Heinz Peter
AU - Delorme, Stefan
AU - Goldschmidt, Hartmut
AU - Weinhold, Niels
AU - Hillengass, Jens
AU - Weber, Marc André
N1 - Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021/3/1
Y1 - 2021/3/1
N2 - The purpose of this study was to analyze size and growth dynamics of focal lesions (FL) as well as to quantify diffuse infiltration (DI) in untreated smoldering multiple myeloma (SMM) patients and correlate those MRI features with timepoint and cause of progression. We investigated 199 whole‐body magnetic resonance imaging (wb‐MRI) scans originating from longitudinal imaging of 60 SMM patients and 39 computed tomography (CT) scans for corresponding osteolytic lesions (OL) in 17 patients. All FLs >5 mm were manually segmented to quantify volume and growth dynamics, and DI was scored, rating four compartments separately in T1‐ and fat‐saturated T2‐ weighted images. The majority of patients with at least two FLs showed substantial spatial heterogeneity in growth dynamics. The volume of the largest FL (p = 0.001, c‐index 0.72), the speed of growth of the fastest growing FL (p = 0.003, c‐index 0.75), the DI score (DIS, p = 0.014, c‐index 0.67), and its dynamic over time (DIS dynamic, p < 0.001, c‐index 0.67) all significantly correlated with the time to progression. Size and growth dynamics of FLs correlated significantly with presence/appearance of OL in CT within 2 years after the respective MRI assessment (p = 0.016 and p = 0.022). DIS correlated with decrease of hemoglobin (p < 0.001). In conclusion, size and growth dynamics of FLs correlate with prognosis and local bone destruction. Connections between MRI findings and progression patterns (fast growing FL—OL; DIS—hemoglobin decrease) might enable more precise diagnostic and therapeutic approaches for SMM patients in the future.
AB - The purpose of this study was to analyze size and growth dynamics of focal lesions (FL) as well as to quantify diffuse infiltration (DI) in untreated smoldering multiple myeloma (SMM) patients and correlate those MRI features with timepoint and cause of progression. We investigated 199 whole‐body magnetic resonance imaging (wb‐MRI) scans originating from longitudinal imaging of 60 SMM patients and 39 computed tomography (CT) scans for corresponding osteolytic lesions (OL) in 17 patients. All FLs >5 mm were manually segmented to quantify volume and growth dynamics, and DI was scored, rating four compartments separately in T1‐ and fat‐saturated T2‐ weighted images. The majority of patients with at least two FLs showed substantial spatial heterogeneity in growth dynamics. The volume of the largest FL (p = 0.001, c‐index 0.72), the speed of growth of the fastest growing FL (p = 0.003, c‐index 0.75), the DI score (DIS, p = 0.014, c‐index 0.67), and its dynamic over time (DIS dynamic, p < 0.001, c‐index 0.67) all significantly correlated with the time to progression. Size and growth dynamics of FLs correlated significantly with presence/appearance of OL in CT within 2 years after the respective MRI assessment (p = 0.016 and p = 0.022). DIS correlated with decrease of hemoglobin (p < 0.001). In conclusion, size and growth dynamics of FLs correlate with prognosis and local bone destruction. Connections between MRI findings and progression patterns (fast growing FL—OL; DIS—hemoglobin decrease) might enable more precise diagnostic and therapeutic approaches for SMM patients in the future.
KW - Anemia
KW - CT
KW - Diffuse infiltration
KW - Focal lesion
KW - MRI
KW - Osteolytic lesion
KW - Prognostic assessment
KW - Progression pattern
KW - Smoldering multiple myeloma
KW - Whole‐body MRI
UR - http://www.scopus.com/inward/record.url?scp=85101330810&partnerID=8YFLogxK
U2 - 10.3390/cancers13050961
DO - 10.3390/cancers13050961
M3 - Article
AN - SCOPUS:85101330810
SN - 2072-6694
VL - 13
SP - 1
EP - 14
JO - Cancers
JF - Cancers
IS - 5
M1 - 961
ER -